» Articles » PMID: 33543485

Progranulin Promotes Bone Fracture Healing Via TNFR Pathways in Mice with Type 2 Diabetes Mellitus

Overview
Specialty Science
Date 2021 Feb 5
PMID 33543485
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Type 2 diabetes mellitus (T2DM) significantly increases bone fragility and fracture risk. Progranulin (PGRN) promotes bone fracture healing in both physiological and type 1 diabetic conditions. The present study aimed to investigate the role of PGRN in T2DM bone fracture healing. MKR mice (with an FVB/N genetic background) were used as the T2DM model. Drill-hole and Bonnarens and Einhorn models were used to investigate the role of PGRN in T2DM fracture healing in vivo. Primary bone marrow cells were isolated for molecular and signaling studies, and reverse transcription-polymerase chain reaction, immunohistochemical staining, and western blotting were performed to assess PGRN effects in vitro. PGRN mRNA and protein expression were upregulated in the T2DM model. Local administration of recombinant PGRN effectively promoted T2DM bone fracture healing in vivo. Additionally, PGRN could induce anabolic metabolism during endochondral ossification through the TNFR2-Akt and Erk1/2 pathways. Furthermore, PGRN showed anti-inflammatory activity in the T2DM bone regeneration process. These findings suggest that local administration of exogenous PGRN may be an alternative strategy to support bone regeneration in patients with T2DM. Additionally, PGRN might hold therapeutic potential for other TNFR-related metabolic disorders.

Citing Articles

Progranulin Protects Against Osteoporosis by Regulating Osteoclast and Osteoblast Balance via TNFR Pathway.

Wang S, Zhang H, Zhu Y, Zhou X, Zhai H, He Q J Cell Mol Med. 2025; 29(3):e70385.

PMID: 39910695 PMC: 11798871. DOI: 10.1111/jcmm.70385.


Progranulin deficiency associates with postmenopausal osteoporosis via increasing ubiquitination of estrogen receptor α.

Li G, Wang A, Tang W, Fu W, Tian Q, Jian J Genes Dis. 2024; 12(1):101221.

PMID: 39559258 PMC: 11570241. DOI: 10.1016/j.gendis.2024.101221.


Advantages and Limitations of Diabetic Bone Healing in Mouse Models: A Narrative Review.

Maisenbacher T, Ehnert S, Histing T, Nussler A, Menger M Biomedicines. 2023; 11(12).

PMID: 38137522 PMC: 10741210. DOI: 10.3390/biomedicines11123302.


Atsttrin regulates osteoblastogenesis and osteoclastogenesis through the TNFR pathway.

Liu K, Wang Z, Liu J, Zhao W, Qiao F, He Q Commun Biol. 2023; 6(1):1251.

PMID: 38081906 PMC: 10713527. DOI: 10.1038/s42003-023-05635-y.


Progranulinopathy: A diverse realm of disorders linked to progranulin imbalances.

Huang G, Jian J, Liu C Cytokine Growth Factor Rev. 2023; 76:142-159.

PMID: 37981505 PMC: 10978308. DOI: 10.1016/j.cytogfr.2023.11.001.


References
1.
Alquezar C, de la Encarnacion A, Moreno F, de Munain A, Martin-Requero A . Progranulin deficiency induces overactivation of WNT5A expression via TNF-α/NF-κB pathway in peripheral cells from frontotemporal dementia-linked granulin mutation carriers. J Psychiatry Neurosci. 2015; 41(4):225-39. PMC: 4915932. DOI: 10.1503/jpn.150131. View

2.
Pearson-Stuttard J, Blundell S, Harris T, Cook D, Critchley J . Diabetes and infection: assessing the association with glycaemic control in population-based studies. Lancet Diabetes Endocrinol. 2015; 4(2):148-58. DOI: 10.1016/S2213-8587(15)00379-4. View

3.
Li H, Zhang Z, Feng D, Xu L, Li F, Liu J . PGRN exerts inflammatory effects via SIRT1-NF-κB in adipose insulin resistance. J Mol Endocrinol. 2020; 64(3):181-193. DOI: 10.1530/JME-19-0211. View

4.
Feng J, Guo F, Jiang B, Zhang Y, Frenkel S, Wang D . Granulin epithelin precursor: a bone morphogenic protein 2-inducible growth factor that activates Erk1/2 signaling and JunB transcription factor in chondrogenesis. FASEB J. 2010; 24(6):1879-92. PMC: 2874481. DOI: 10.1096/fj.09-144659. View

5.
Hotamisligil G . The role of TNFalpha and TNF receptors in obesity and insulin resistance. J Intern Med. 1999; 245(6):621-5. DOI: 10.1046/j.1365-2796.1999.00490.x. View